Remember, the 178th Annual Meeting of the FDA Advisory Committee on the future of Covid-19 Vaccination Regimens is this Thursday from 8:30 AM-5:30 ET.
The details so far include the voting question:
“Simplification of current COVID-19 vaccine use:
- Vaccine composition: Does the committee recommend harmonizing the
vaccine strain composition of primary series and booster doses in the U.S.
to a single composition, e.g., the composition for all vaccines administered
currently would be a bivalent vaccine (Original plus Omicron BA.4/BA.5)?”